Various impacts of driver mutations on the PD-L1 expression of NSCLC. Bằng Cheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeng-Sen Tseng, Tsung-Ying Yang, Gee-Chen Chang

lấy văn bản

Primary tumor consolidative therapy improves the outcomes of patients with advanced -mutant lung adenocarcinoma treated with first-line osimertinib Bằng Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng, Cheng-Hsiang Chu, Kun-Chieh Chen, Mong-Wei Lin, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Tsung-Ying Yang, Sung-Liang Yu, Jin-Shing Chen, Chao-Chi Ho, Gee-Chen Chang

lấy văn bản

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma Bằng Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Chun-Ju Chiang, Chun-Ju Chiang, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Kun-Chieh Chen, Kun-Chieh Chen, Cheng-Hsiang Chu, Cheng-Hsiang Chu, Yen-Hsiang Huang, Yen-Hsiang Huang, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Wen-Chung Lee, Wen-Chung Lee, Tsung-Ying Yang, Tsung-Ying Yang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang

lấy văn bản